Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2015 Filed Jul 1, 2015 20:34 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 439.1358 | $56.93 | $25,000.00 |
DisclosureSEC source: 0001225208-15-014678 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,993.5801 Underlying: Common Stock · 439.1358 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2015 Filed Jul 1, 2015 20:34 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 636.7469 | $56.93 | $36,250.00 |
DisclosureSEC source: 0001225208-15-014677 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,519.728 Underlying: Common Stock · 636.7469 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2015 Filed Jul 1, 2015 20:34 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 483.0494 | $56.93 | $27,500.00 |
DisclosureSEC source: 0001225208-15-014679 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,057.0277 Underlying: Common Stock · 483.0494 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| June 30, 2015 Filed Jul 1, 2015 20:34 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 439.1358 | $56.93 | $25,000.00 |
DisclosureSEC source: 0001225208-15-014680 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,162.1891 Underlying: Common Stock · 439.1358 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
BRUN LESLIE ADirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013054 · doc4.xml · derivative · entry 2 BRUN LESLIE A · CIK 0001217068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,782.3837 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013055 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,723.0533 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013056 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,573.9783 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
Thompson Craig B.Director
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013057 · doc4.xml · derivative · entry 2 Thompson Craig B. · CIK 0001423419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,686.6487 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013058 · doc4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,686.6487 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
REPRESAS CARLOS EDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013059 · doc4.xml · derivative · entry 3 REPRESAS CARLOS E · CIK 0001216083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,298.1807 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
LAZARUS ROCHELLE BDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013060 · doc4.xml · derivative · entry 3 LAZARUS ROCHELLE B · CIK 0001082206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,554.4443 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
KIDDER C ROBERTDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013061 · doc4.xml · derivative · entry 3 KIDDER C ROBERT · CIK 0001179703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,686.6497 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013062 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,915.5797 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013063 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,882.9811 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 29, 2015 Filed Jun 1, 2015 18:50 UTC |
Cech Thomas RDirector
|
GrantPhantom Stock · Derivative | 2,463.4587 | $60.89 | $150,000.00 |
DisclosureSEC source: 0001225208-15-013064 · doc4.xml · derivative · entry 2 Cech Thomas R · CIK 0001464680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,160.9477 Underlying: Common Stock · 2,463.4587 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 11, 2015 Filed May 11, 2015 21:48 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
SaleCommon Stock | 10,634 | $60.44 | $642,767.88 |
DisclosureSEC source: 0001225208-15-011867 · doc4.xml · nonDerivative · entry 1 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.3100 to $60.6400, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:33 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionStock Option (right to buy) · Derivative | 19,208 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-15-011802 · doc4.xml · derivative · entry 5 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,208 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable in three equal installments beginning on 5/7/2011, 5/7/2012, and 5/7/2013. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:33 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-15-011802 · doc4.xml · derivative · entry 4 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,313 Underlying: Common Stock · 27,000 shares Expires 2021-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable in three equal installments beginning on 5/4/2012, 5/4/2013 and 5/4/2014. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:33 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
SaleCommon Stock | 38,368 | $60.99 | $2,339,949.22 |
DisclosureSEC source: 0001225208-15-011802 · doc4.xml · nonDerivative · entry 3 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,985.356 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.7400 to $61.1500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:33 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionCommon Stock | 19,208 | $33.49 | $643,275.92 |
DisclosureSEC source: 0001225208-15-011802 · doc4.xml · nonDerivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,353.356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2015 Filed May 11, 2015 17:33 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionCommon Stock | 27,000 | $36.56 | $987,120.00 |
DisclosureSEC source: 0001225208-15-011802 · doc4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,145.356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 56,064 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · derivative · entry 7 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,064 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested and became exercisable in three equal installments on 5/2/2013, 5/2/2014 and 5/2/2015. Read SEC document |
| May 04, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
SaleCommon Stock | 56,064 | $60.20 | $3,374,794.91 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · nonDerivative · entry 4 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,432.143 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0500 to $60.4200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 56,064 | $39.29 | $2,202,754.56 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · nonDerivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,496.143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,708 | $59.86 | $700,840.88 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · derivative · entry 6 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,708 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Tax withholdingCommon Stock | 6,071 | $59.86 | $363,410.06 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · nonDerivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,432.143 Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
Exercise / conversionCommon Stock | 11,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011270 · doc4.xml · nonDerivative · entry 1 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,503.143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,818 | $59.86 | $228,545.48 |
DisclosureSEC source: 0001225208-15-011271 · doc4.xml · derivative · entry 5 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,818 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Tax withholdingCommon Stock | 1,423 | $59.86 | $85,180.78 |
DisclosureSEC source: 0001225208-15-011271 · doc4.xml · nonDerivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,371.005 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionCommon Stock | 3,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011271 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,794.005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,636 | $59.86 | $457,090.96 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · derivative · entry 5 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,636 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Tax withholdingCommon Stock | 3,438 | $59.86 | $205,798.68 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · nonDerivative · entry 2 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,193.0118 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Deese Willie AExe V-P & Pres. MMD
|
Exercise / conversionCommon Stock | 7,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011272 · doc4.xml · nonDerivative · entry 1 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,631.0118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,090 | $59.86 | $304,687.40 |
DisclosureSEC source: 0001225208-15-011273 · doc4.xml · derivative · entry 5 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,090 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
Tax withholdingCommon Stock | 2,640 | $59.86 | $158,030.40 |
DisclosureSEC source: 0001225208-15-011273 · doc4.xml · nonDerivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,924.323 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
Exercise / conversionCommon Stock | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011273 · doc4.xml · nonDerivative · entry 1 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,564.323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,818 | $59.86 | $228,545.48 |
DisclosureSEC source: 0001225208-15-011274 · doc4.xml · derivative · entry 4 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,818 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Tax withholdingCommon Stock | 1,214 | $59.86 | $72,670.04 |
DisclosureSEC source: 0001225208-15-011274 · doc4.xml · nonDerivative · entry 2 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,145.356 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy
|
Exercise / conversionCommon Stock | 3,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011274 · doc4.xml · nonDerivative · entry 1 Gerberding Julie L. · CIK 0001628884 · EVP Strat Comm, Gl Pub Policy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,359.356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Golestani ClarkEVP & Chief Info Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,291 | $59.86 | $137,139.26 |
DisclosureSEC source: 0001225208-15-011275 · doc4.xml · derivative · entry 5 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,291 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Golestani ClarkEVP & Chief Info Officer
|
Tax withholdingCommon Stock | 854 | $59.86 | $51,120.44 |
DisclosureSEC source: 0001225208-15-011275 · doc4.xml · nonDerivative · entry 2 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,405.12 F1 · balance_after: Since the date of the reporting person's last ownership report, Mr. Golestani transferred 2,012 shares of common stock of Merck & Co., Inc. to his former spouse pursuant to a domestic relations order. The reporting person will no longer report as beneficially owned any security owned by his former spouse. Holdings also include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Golestani ClarkEVP & Chief Info Officer
|
Exercise / conversionCommon Stock | 2,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011275 · doc4.xml · nonDerivative · entry 1 Golestani Clark · CIK 0001563786 · EVP & Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,259.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,654 | $59.86 | $518,028.44 |
DisclosureSEC source: 0001225208-15-011276 · doc4.xml · derivative · entry 4 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,654 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Tax withholdingCommon Stock | 4,488 | $59.86 | $268,651.68 |
DisclosureSEC source: 0001225208-15-011276 · doc4.xml · nonDerivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,845.754 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Exercise / conversionCommon Stock | 8,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011276 · doc4.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,333.754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,709 | $59.86 | $281,880.74 |
DisclosureSEC source: 0001225208-15-011277 · doc4.xml · derivative · entry 5 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,709 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Tax withholdingCommon Stock | 1,755 | $59.86 | $105,054.30 |
DisclosureSEC source: 0001225208-15-011277 · doc4.xml · nonDerivative · entry 2 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,373.566 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Karachun Rita ASr. VP Fince-Global Controller
|
Exercise / conversionCommon Stock | 4,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-15-011277 · doc4.xml · nonDerivative · entry 1 Karachun Rita A · CIK 0001601572 · Sr. VP Fince-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,128.566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,818 | $59.86 | $228,545.48 |
DisclosureSEC source: 0001225208-15-011278 · doc4.xml · derivative · entry 4 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,818 shares Expires 2015-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2015 Filed May 5, 2015 20:46 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
Tax withholdingCommon Stock | 1,980 | $59.86 | $118,522.80 |
DisclosureSEC source: 0001225208-15-011278 · doc4.xml · nonDerivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,553.64 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.